On January 22, 2010 the FDA approved AMPYRA™ (dalfampridine). AMPYRA, which was previously referred to as Fampridine-SR, is an extended release tablet formulation of dalfampridine (4-aminopyridine, 4-AP), which was previously called fampridine. For more information on AMPYRA, click here.